Management of Small Solitary Pulmonary Nodules

Risk Stratification

The Fleischner Society recommends assessing smoking history carefully, as current smokers or recent quitters are classified as high-risk, while never-smokers have approximately 85% lower relative risk 1, 4
Evaluate nodule characteristics, such as upper lobe location, spiculated margins, or irregular morphology, which increase malignancy risk to 1-5% even for nodules in the 6-8 mm range 1, 3, 4

The Fleischner Society 2017 guidelines recommend initial CT surveillance at 6-12 months from baseline (Grade 1B recommendation) for 6-8 mm solid nodules, with an estimated malignancy risk of 0.5-2.0% 1, 2, 3, 4
A second follow-up CT at 18-24 months from baseline completes the surveillance protocol 1, 2, 3
Use low-dose technique without IV contrast for all follow-up examinations to minimize radiation exposure 5
Ensure thin-section imaging (1.5 mm contiguous sections) for accurate nodule characterization and measurement 1, 2

High-risk features, such as spiculation, upper lobe location, or irregular margins, warrant earlier follow-up (6 months) for initial follow-up 1, 3, 4
Patient comorbidities and preferences should inform the exact timing within the recommended ranges 1, 3

Use the average of long and short axes, rounded to the nearest millimeter, for nodule measurement 1, 2
Volumetric measurements (using 100-250 mm³ thresholds) are acceptable alternatives if consistent software is used for all follow-up studies 1, 2

Documented growth requires consideration of PET-CT, biopsy, or surgical resection 3
Nodule reaches ≥8 mm on follow-up imaging triggers evaluation with PET-CT, tissue sampling, or 3-month surveillance depending on morphology 1, 3, 4
Development of suspicious morphologic features (spiculation, irregular margins) during surveillance 1, 3
Volume doubling time <400 days indicates aggressive behavior requiring further workup 7

At age 67, consider lung cancer screening eligibility if the patient has a significant smoking history (20+ pack-years) 8
Two follow-up examinations should be sufficient to exclude growth in most patients with stable nodules 1, 3
After demonstrating stability at 18-24 months, no further routine follow-up is typically needed for solid nodules in this size range 1, 3